Angiotensin II test for treating vasoplegic shock
Part of Heart & circulation, Infections clinical trials.
This trial tests a medicine called angiotensin II to see how well it helps people whose blood pressure stays dangerously low after standard treatments for vasoplegic shock, a condition where blood vessels relax too much. If it works, it might help raise blood pressure and improve blood flow to vital organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had vasoplegic shock for less than 72 hours.
- Your blood pressure is still lower than target (65-85 mmHg) even after fluids and two standard blood-pressure-raising medicines (noradrenaline and vasopressin).
- You have not previously received angiotensin II.
- Your expected survival is more than 24 hours and you are not limited in receiving active treatment.
- You do not have any of the excluded conditions, such as severe burns, acute heart problems, severe bleeding, liver failure, or need for ECMO.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a blood test called renin to guide treatment can help stabilize blood pressure in ICU patients with shock. It may help doctors choose the right medications and targets to reduce complications.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial studies whether aiming for a higher average blood pressure (using medicines) can better protect kidney function in critically ill adults with shock. You may be asked to have close kidney and heart monitoring while receiving blood-pressure support.
This trial is testing a new system called Argos to see if it can measure how much blood your heart pumps more easily than current methods. It is for patients already in the ICU who need a quick change in fluids or blood pressure medicine.
This study tests an IV medicine called angiotensin II (Giapreza) to raise blood pressure in children who are very sick and not responding to standard treatments. It aims to see if this medicine can help stabilize blood pressure and improve outcomes.
This study tests an injection of angiotensin II (a substance that helps tighten blood vessels) versus a placebo for patients with distributive shock that is not responding to standard treatments. It may help raise blood pressure and improve outcomes.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.